WeLeader Biomedical Co., Ltd. (7713) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for WeLeader Biomedical Co., Ltd. (7713:TWSE), powered by AI.

Current Price
$72.00
Sector
Healthcare
What is the WeLeader Biomedical Co., Ltd. stock price forecast?

WeLeader Biomedical Co., Ltd. is currently trading at $72.00. View real-time AI analysis on Alpha Lenz.

What is WeLeader Biomedical Co., Ltd. insider trading activity?

View the latest insider trading data for WeLeader Biomedical Co., Ltd. on Alpha Lenz.

What is WeLeader Biomedical Co., Ltd.'s P/E ratio?

View WeLeader Biomedical Co., Ltd.'s valuation metrics on Alpha Lenz.

WeLeader Biomedical Co., Ltd.

TWSE · 7713
NT$72.00+1.00(+1.41%)
Ask about WeLeader Biomedical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

WeLeader Biomedical Co., Ltd.'s ROE is 19.2%. Explore profitability and growth together.

Ask for details

Company Overview

WeLeader Biomedical Co., Ltd. is a Taiwan-based healthcare company specializing in the distribution and agency of in vitro diagnostic products, medical diagnostic equipment, and reagent-related services. Founded in 1992 and headquartered in Kaohsiung, the company provides a broad portfolio, including serum biochemistry integration platforms, blood gas and urine analyzers, immunoassay systems, and POCT (point-of-care testing) solutions. It supports a comprehensive range of stakeholders such as hospitals, laboratories, research institutions, and schools, offering product distribution, after-sales support, maintenance, operational coaching, and digital medical examination platforms. Market activity is primarily domestic, and the firm plays a key role in advancing automated diagnostics and integrated laboratory management within Taiwan's healthcare sector. Through its ongoing innovations in laboratory automation and medical information systems, WeLeader Biomedical is recognized as an important contributor to the efficiency and modernization of healthcare diagnostics and laboratory workflows.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.11BRevenue
0.00Shares Out
0Employees

Margins

33.44%Gross
35.43%EBITDA
23.54%Operating
23.53%Pre-Tax
18.80%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

2.31%Rev 3Yr
10.46%Rev 5Yr
10.39%Op Inc 3Yr
30.89%Op Inc 5Yr
10.69%Net Inc 3Yr
33.56%Net Inc 5Yr

Returns

9.38%ROA
19.23%ROE
12.10%ROIC

Financial Health

NT$237.71MCash & Cash Equivalents
NT$951.15MNet Debt
94.35%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

WeLeader Biomedical Co., Ltd. (ticker: 7713) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 72 with a P/E ratio of -x and P/B of -x.

ROE is 19.23% and operating margin is 23.54%. Annual revenue is $1.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
WeLeader Biomedical Co., Ltd. (7713) Stock Forecast 2026 $72.00 — Price, Financials & Analyst Targets | Alpha Lenz